China Pharma (CPHI) Stock: Buy, Sell, or Hold?
CPHI - China Pharma Holdings, Inc.
$0.68
-0.04 (-5.19%)
âŧ
5d:
+1.18%
30d:
-25.02%
90d:
+2.7%
WAIT
LOW Confidence
Analysis Updated: Sep 29, 2026 12:00 AM ET
Earnings: Nov 11, 2026
Get Alerted When CPHI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: CPHI is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: CPHI is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: CPHI is currently trading at $0.68, which is considered slightly low relative to its 30-day fair value range of $0.72 to $0.96.
Technical Outlook: Technically, CPHI is showing sideways momentum. Immediate support is located at $0.65, while resistance sits at $0.94. Short-term momentum is weak, with the stock down 5.2% recently.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $3.00 (+319.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CPHI is showing sideways momentum. Immediate support is located at $0.65, while resistance sits at $0.94. Short-term momentum is weak, with the stock down 5.2% recently.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $3.00 (+319.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$0.72 -
$0.96
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-5.2%)
- BULLISH: Trading 319.6% below Wall St target ($3.00)
- WARNING: Composite score 47/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.72 -
$0.96
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$0.65
Resistance Level
$0.94
Current Trend
Sideways
Technical data as of
Sep 28, 2026
Fundamental Context
Forward P/E (Next Year Est.)
1.56
Wall Street Target
$3.00
(+319.6%)
Revenue Growth (YoY)
-7.5%
Profit Margin
-114.3%
Share & Embed Analysis
Last updated: September 29, 2026 11:51 AM ET
Data refreshes hourly during market hours. Next update: 12:51 PM
Data refreshes hourly during market hours. Next update: 12:51 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CPHI showing a specific setup today?
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences IâĻ |
STRONG BUY
25 analysts |
$208 | 55 HOLD |
|
BCRX
BioCryst PharmaceuticalsâĻ |
STRONG BUY
12 analysts |
$21 | 68 BUY |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$96 | 60 HOLD |
|
UTHR
United Therapeutics CorpâĻ |
STRONG BUY
15 analysts |
$638 | 51 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$108 | 48 HOLD |
